相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection
Paolo Strati et al.
BLOOD (2019)
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing Pan et al.
LEUKEMIA (2019)
Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
Caterina Sagnelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
Shigeru Kusumoto et al.
BLOOD (2019)
CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell Lymphoma
Caron A. Jacobson
JOURNAL OF CLINICAL ONCOLOGY (2019)
CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
Julio C. Chavez et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
Victor A. Chow et al.
BLOOD (2018)
How I manage patients with relapsed/refractory diffuse large B cell lymphoma
Christian Gisselbrecht et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
Marek Trneny et al.
HAEMATOLOGICA (2018)
CAR T-cell therapy in refractory large B-cell lymphoma
Robert Stirrups
LANCET ONCOLOGY (2018)
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
Marek Trneny et al.
HAEMATOLOGICA (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper
L. Sarmati et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
Shigeru Kusumoto et al.
CLINICAL INFECTIOUS DISEASES (2015)
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
K. Rajender Reddy et al.
GASTROENTEROLOGY (2015)
Hepatitis B virus reactivation with a rituximab-containing regimen
Yutaka Tsutsumi et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy A Randomized Clinical Trial (vol 312, pg 2521, 2014)
He Huang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy A Randomized Clinical Trial
He Huang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
Seok Jin Kim et al.
EUROPEAN JOURNAL OF CANCER (2013)
Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis
Hua-Jie Dong et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
Shigeru Kusumoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
分享论文
